Education
About Us
Working with TipRanks
Follow Us
Kidswell Bio Corporation (JP:4584)
:4584
Total Valuation
Kidswell Bio Corporation has a market cap or net worth of ¥12.14B. The enterprise value is ¥11.95B.
Market Cap¥12.14B
Enterprise Value¥11.95B
Share Statistics
Kidswell Bio Corporation has 49,559,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,559,820
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kidswell Bio Corporation’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is -0.24%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-0.24%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee133.74M
Profits Per Employee-556.32K
Employee Count38
Asset Turnover0.73
Inventory Turnover2.33
Valuation Ratios
The current PE Ratio of Kidswell Bio Corporation is 35.8. Kidswell Bio Corporation’s PEG ratio is 2.17.
PE Ratio35.8
PS Ratio0.89
PB Ratio3.22
Price to Fair Value3.22
Price to FCF4.88
Price to Operating Cash Flow0.00
PEG Ratio2.17
Income Statement
In the last 12 months, Kidswell Bio Corporation had revenue of 5.08B and earned -21.14M in profits. Earnings per share was -0.52.
Revenue5.08B
Gross Profit1.64B
Operating Income27.88M
Pretax Income72.87M
Net Income-21.14M
EBITDA116.26M
Earnings Per Share (EPS)-0.52
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kidswell Bio Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.12
52-Week Price Change109.40%
50-Day Moving Average263.56
200-Day Moving Average196.09
Relative Strength Index (RSI)43.05
Average Volume (3m)946.59K
Important Dates
Kidswell Bio Corporation upcoming earnings date is Nov 13, 2025, TBA (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 13, 2025
Ex-Dividend Date―
Financial Position
Kidswell Bio Corporation as a current ratio of 1.55, with Debt / Equity ratio of 75.62%
Current Ratio1.55
Quick Ratio1.21
Debt to Market Cap0.41
Net Debt to EBITDA-9.96
Interest Coverage Ratio0.66
Taxes
In the past 12 months, Kidswell Bio Corporation has paid 94.01M in taxes.
Income Tax94.01M
Effective Tax Rate1.29
Enterprise Valuation
Kidswell Bio Corporation EV to EBITDA ratio is 29.06, with an EV/FCF ratio of 3.63.
EV to Sales0.66
EV to EBITDA29.06
EV to Free Cash Flow3.63
EV to Operating Cash Flow3.61
Balance Sheet
Kidswell Bio Corporation has ¥2.84B in cash and marketable securities with ¥1.55B in debt, giving a net cash position of ¥1.29B billion.
Cash & Marketable Securities¥2.84B
Total Debt¥1.55B
Net Cash¥1.29B
Net Cash Per Share¥26.06
Tangible Book Value Per Share¥34.82
Margins
Gross margin is 31.86%, with operating margin of 0.55%, and net profit margin of -0.42%.
Gross Margin31.86%
Operating Margin0.55%
Pretax Margin1.43%
Net Profit Margin-0.42%
EBITDA Margin2.29%
EBIT Margin2.27%
Analyst Forecast
The average price target for Kidswell Bio Corporation is ¥249.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥249.00
Price Target Upside1.63% Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast120.34%
EPS Growth Forecast―